Skip to main content
. Author manuscript; available in PMC: 2018 Mar 18.
Published in final edited form as: Nature. 2017 Jul 31;548(7668):466–470. doi: 10.1038/nature23470

Figure 4. STING signaling is required for maximal anti-CTLA4 therapy driven abscopal responses in the B16 murine melanoma model.

Figure 4

a, Schematic of the modified RadVax procedure. b, Growth of Wild-type (B16) or STING Knockout (KO) abscopal tumors following injection of untreated cells, or cells treated with 10Gy 3 days before implantation. All mice received 9H10 anti-CTLA4 antibody as described in a. p-value is from the mixed effect linear model. Number of mice for each group is indicated within parentheses. c, Static tumor volumes at day 15 as measured in (b). e, Fraction of CD8+ cytotoxic T cells as a percent of CD45+ cells infiltrating the abscopal tumor. f, Model as described in the text. Pairwise comparisons by Mann-Whitney test, all error bars are SEM of biological replicates.